MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $358,000 | -71.9% | 11,760 | -81.8% | 0.03% | -69.8% |
Q4 2020 | $1,275,000 | -22.1% | 64,474 | -48.6% | 0.09% | -20.4% |
Q3 2020 | $1,636,000 | -80.7% | 125,449 | -61.8% | 0.11% | -68.3% |
Q2 2017 | $8,481,000 | +129.1% | 328,200 | +47.8% | 0.34% | +40.3% |
Q4 2016 | $3,702,000 | +5.5% | 222,056 | +30.2% | 0.24% | +18.5% |
Q3 2016 | $3,509,000 | -17.8% | 170,500 | +22.2% | 0.20% | -39.3% |
Q2 2016 | $4,269,000 | -18.2% | 139,500 | 0.0% | 0.34% | +3.4% |
Q1 2016 | $5,221,000 | +50.9% | 139,500 | +73.9% | 0.33% | -31.0% |
Q4 2015 | $3,461,000 | +27.7% | 80,200 | +10.9% | 0.47% | +677.0% |
Q3 2015 | $2,710,000 | +63.9% | 72,314 | +48.7% | 0.06% | +41.9% |
Q2 2015 | $1,653,000 | +51.9% | 48,642 | +72.4% | 0.04% | +53.6% |
Q3 2014 | $1,088,000 | -11.7% | 28,214 | -10.8% | 0.03% | -15.2% |
Q2 2014 | $1,232,000 | +4.3% | 31,642 | -8.4% | 0.03% | +17.9% |
Q1 2014 | $1,181,000 | -88.3% | 34,556 | -92.0% | 0.03% | -89.8% |
Q3 2013 | $10,122,000 | +121.1% | 430,743 | +152.8% | 0.27% | +132.2% |
Q2 2013 | $4,578,000 | – | 170,373 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |